We are currently in a phase 1 trial of our HIV cell therapy that is U.S.-only. If it is successful, we hope to expand internationally for future trials and commercialization.
We are not a large pharmaceutical company, so our first human trial is only being conducted at local test sites in the Maryland/DC area in the U.S. We will try to partner with a large pharma after this trial to facilitate the next steps in the regulatory process (phases 2 and 3, approvals, etc.) which may entail a larger geographic area for further clinical trials. Should this treatment gain approval, we will work hard to get it distributed worldwide as quickly as possible.